GCI

18th November 2024
12:43

Harwood Capital Mgmt - Form 8.3 - Tissue Regenix Group PLC

14th November 2024
09:19

Cavendish Securities - Form 8.5 (EPT/NON-RI)

13th November 2024
09:32

Richard Griffiths - Form 8.3 - Tissue Regenix Group Plc

12th November 2024
16:05

Tissue Regenix Group - Form 8 (OPD) (Tissue Regenix Group Plc)

12th November 2024
08:46

Cavendish Securities - Form 8.5 (EPT/NON-RI)

11th November 2024
09:17

Cavendish Securities - Form 8.5 (EPT/NON-RI)

7th November 2024
09:59

Cavendish Securities - Form 8.5 (EPT/NON-RI) - Tissue Regenix Group PLC

6th November 2024
13:37

Lombard Odier - Form 8.3 - Tissue Regenix Group PLC

6th November 2024
08:52

Cavendish Securities - Form 8.5 (EPT/NON-RI)

5th November 2024
14:24

Tissue Regenix Group - Form 8.3 - Tissue Regenix Group PLC

5th November 2024
11:32

Cavendish Securities - Form 8.5 (EPT/NON-RI)

4th November 2024
16:36

Tissue Regenix Group - Response to media speculation

10th September 2024
06:00

Tissue Regenix Group - Interim results for the six months ended 30 June

21st August 2024
06:00

Tissue Regenix Group - Confirmation of results

18th July 2024
14:52

Tissue Regenix Group - Grant of share options

16th July 2024
06:00

Tissue Regenix Group - Half-Year Trading Update

3rd July 2024
12:16

Tissue Regenix Group - Holding(s) in Company

24th June 2024
15:12

Tissue Regenix Group - Holding(s) in Company

Tissue Regenix Group Plc (TRX.L) Share Price & News

Bid

-

-

-

Ask

High
-
OPEN
-
VOL
-
MKT CAP
-M

LOW
-
CLOSE
-
SHARES IN ISSUE
70.57M

Tissue Regenix Group Plc Company Profile

Tissue Regenix Group is a pioneering, international medical technology company, focusing on the development of regenerative products

Watchlist